# Pierre‐Yves Courand

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/pierre-yves-courand/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,663 |
| Field | Blood Pressure and Hypertension Studies |
| h-index | 31 |
| i10-index | 63 |
| Last Known Institution | Lyon 1 Université |
| OpenAlex ID | https://openalex.org/A5034153547 |
| ORCID iD | 0000-0003-3199-7977 |
| Works | 223 |

## Researcher papers

- [Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial](https://scholariq.org/papers/endovascular-ultrasound-renal-denervation-to-treat-hypertension-radiance-htn/)
- [Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial](https://scholariq.org/papers/optimum-and-stepped-care-standardised-antihypertensive-treatment-with-or-without/)
- [Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial](https://scholariq.org/papers/ultrasound-renal-denervation-for-hypertension-resistant-to-a-triple-medication/)
- [A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor–Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention](https://scholariq.org/papers/a-genetic-mouse-model-recapitulates-immune-checkpoint-inhibitor-associated/)
- [Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial](https://scholariq.org/papers/dual-endothelin-antagonist-aprocitentan-for-resistant-hypertension-precision-a/)
- [Adherence to Antihypertensive Treatment and the Blood Pressure–Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial](https://scholariq.org/papers/adherence-to-antihypertensive-treatment-and-the-blood-pressure-lowering-effects/)
- [Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis](https://scholariq.org/papers/cardiomuscular-biomarkers-in-the-diagnosis-and-prognostication-of-immune/)
- [Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial](https://scholariq.org/papers/six-month-results-of-treatment-blinded-medication-titration-for-hypertension/)
- [Clinical and Genetic Spectrum of Bartter Syndrome Type 3](https://scholariq.org/papers/clinical-and-genetic-spectrum-of-bartter-syndrome-type-3/)
- [Fractional Flow Reserve to Guide Treatment of Patients With Multivessel Coronary Artery Disease](https://scholariq.org/papers/fractional-flow-reserve-to-guide-treatment-of-patients-with-multivessel-coronary/)
- [Renal replacement therapy in type 2 severe cardiorenal syndrome: a randomized controlled trial](https://scholariq.org/papers/renal-replacement-therapy-in-type-2-severe-cardiorenal-syndrome-a-randomized/)

## Researcher topics

- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Cardiovascular Health and Disease Prevention](https://scholariq.org/topics/cardiovascular-health-and-disease-prevention/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)

## Researcher university

- [Lyon 1 Université](https://scholariq.org/institutions/lyon-1-universite/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.